Cargando…

Refractory asthma: mechanisms, targets, and therapy

Asthma is a common medical condition affecting 300 million people worldwide. Airway inflammation, smooth muscle bronchoconstriction leading to airflow obstruction, and mucous hypersecretion are clinical hallmarks of asthma. The NHLBI Expert Panel Report 3 recommends inhaled corticosteroids (ICS) for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trevor, J L, Deshane, J S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279947/ https://www.ncbi.nlm.nih.gov/pubmed/24773466 http://dx.doi.org/10.1111/all.12412

Ejemplares similares

Airway Remodeling in Asthma
por: Hough, Kenneth P., et al.
Publicado: (2020)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Reslizumab as add-on therapy in patients with refractory asthma
por: Virchow, J Christian, et al.
Publicado: (2020)

Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Optimal Management of Severe/Refractory Asthma
por: Pakhale, Smita, et al.
Publicado: (2011)

Recommendation for optimal management of severe refractory asthma
por: Morjaria, Jaymin B, et al.
Publicado: (2010)

An underlying mechanism behind interventional pulmonology techniques for refractory asthma treatment: Neuro-immunity crosstalk
por: Liao, Ximing, et al.
Publicado: (2023)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Eosinophils Target Therapy for Severe Asthma: Critical Points
por: Brussino, L., et al.
Publicado: (2018)

Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer
por: Patel, Jesal C., et al.
Publicado: (2013)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

Managing the pediatric patient with refractory asthma: a multidisciplinary approach
por: Cook, James, et al.
Publicado: (2017)

Cytokine-targeted therapies for asthma and COPD
por: Schleich, Florence, et al.
Publicado: (2023)

Asthma Endotypes and an Overview of Targeted Therapy for Asthma
por: Svenningsen, Sarah, et al.
Publicado: (2017)

Airway smooth muscle as a target of asthma therapy: history and new directions
por: Janssen, Luke J, et al.
Publicado: (2006)

Cardiac Tamponade Presenting as Refractory Asthma
por: Rosen, Sasha
Publicado: (2013)

Asthma and Therapeutics: Recombinant Therapies in Asthma
por: Cockcroft, Donald W
Publicado: (2005)

Targeted therapy in severe asthma today: focus on immunoglobulin E
por: Pelaia, Girolamo, et al.
Publicado: (2017)

Airway and serum biochemical correlates of refractory neutrophilic asthma
por: Alam, Rafeul, et al.
Publicado: (2017)

The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma
por: Sellin, Mark, et al.
Publicado: (2022)

Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL
por: Zhang, Jing, et al.
Publicado: (2023)

Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia
por: Ma, Jiale, et al.
Publicado: (2021)

Endogenous inhibitory mechanisms in asthma
por: Chiarella, Sergio E., et al.
Publicado: (2023)

Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in Asthma
por: Dong, Zhiyong, et al.
Publicado: (2016)

Obesity-Related Asthma: Immune Regulation and Potential Targeted Therapies
por: Yuan, Yuze, et al.
Publicado: (2018)

Occupational exposures, smoking and airway inflammation in refractory asthma
por: Simpson, Jodie L, et al.
Publicado: (2014)

Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat
por: Raychaudhuri, Ruben, et al.
Publicado: (2022)

Targeting TSLP in Asthma
por: Parnes, Jane R, et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cells in Asthma Therapy: Mechanisms and Strategies for Enhancement
por: Huang, Si, et al.
Publicado: (2023)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies
por: La Via, Luigi, et al.
Publicado: (2022)

Targeting HDAC Complexes in Asthma and COPD
por: Zwinderman, Martijn R. H., et al.
Publicado: (2019)

Exercise Limitation in Children and Adolescents With Severe Refractory Asthma: A Lack of Asthma Control?
por: Faleiro, Rita C., et al.
Publicado: (2021)

Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry
por: Kim, Min-Hye, et al.
Publicado: (2018)

Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review)
por: Fildan, Ariadna Petronela, et al.
Publicado: (2021)

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
por: Howell, Imran, et al.
Publicado: (2023)

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy
por: Bagnasco, Diego, et al.
Publicado: (2023)

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab
por: Cheng, Shih-Lung
Publicado: (2021)

Development of New Therapies for Severe Asthma
por: Fajt, Merritt L., et al.
Publicado: (2017)

Tumor refractoriness to anti-VEGF therapy
por: Ribatti, Domenico
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_53h5ajrr2ecjelch218bbud492